{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04096",
    "Peptide Name": "PN7 (Plectasin D9Y,M13G,Q14R, plectasin analog, synthetic AMPs, 3S=S, UCSS1a)",
    "Source": "Amino acid substitution, fungal defensin analog, fungi-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GFGCNGPWYEDDGRCHNHCKSIKGYKGGYCAKGGFVCKCY",
    "Sequence Length": 40,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Bridge",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": 1.45,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "30%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (92.5%) toPlectasinActivity: Active against S. aureus 43300 MRSA or ATCC 25923 or E48 or 546 (MIC 1-16 ug/ml), S. epidermidis ATCC 35984 (MIC 16 ug/ml), S. hyicus 437-2 or NCTC 10350 (MIC 4-8 ug/ml), Streptococcus. suis CVCC 606 (MIC 1 ug/ml), S. agalactiae ATCC 13813 or CAU-FRI-4 (MIC 1-2 ug/ml), (MIC 1-16 ug/ml), (MIC 1-16 ug/ml), (MIC 1-16 ug/ml), (MIC 1-16 ug/ml), Gram- E.coli (MIC > 128 ug/ml), S.enterica ATCC 13076 (MIC > 128 ug/ml), S.enteritidis CVCC 3377 (MIC > 128 ug/ml), S.pullorum CVCC 1789 (MIC > 128 ug/ml), P.aeruginosa (MIC > 128 ug/ml), and C.albicans (MIC > 128 ug/ml).Antimicrobial robustness: activity is pH-insensitive (pH 2-10).Toxicity: not hemo.lytic up to 128 ug/ml.Recombinant production:yeast:Pichia pastoris: expressed and purified in a fermentor.",
    "Author": "Hao Y, Teng D, Mao R, Yang N, Wang J. 2023",
    "Reference": "Antibiotics (Basel). 2023 Aug 3;12(8):1283. doi: 10.3390/antibiotics12081283.PubMed",
    "Title": "Site Mutation Improves the Expression and Antimicrobial Properties of Fungal Defense."
  },
  "3D Structure": []
}